Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Thromb Haemost. 2021 Dec;121(12):1677-1680. doi: 10.1055/a-1585-6182. Epub 2021 Sep 23.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies / blood*
  • Biomarkers / blood
  • ChAdOx1 nCoV-19 / administration & dosage
  • ChAdOx1 nCoV-19 / adverse effects*
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Male
  • Middle Aged
  • Platelet Factor 4 / immunology*
  • Pulmonary Embolism / chemically induced*
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / immunology
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / drug therapy
  • Thrombocytopenia / immunology
  • Treatment Outcome
  • Vaccination / adverse effects*
  • Venous Thromboembolism / chemically induced*
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / immunology
  • Venous Thrombosis / chemically induced*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / immunology

Substances

  • Antibodies
  • Biomarkers
  • Immunoglobulins, Intravenous
  • PF4 protein, human
  • Platelet Factor 4
  • ChAdOx1 nCoV-19